Belgium· BE-AMP-SAM303843-00

Priorix-Tetra

A masern, kombinationen mit mumps, röteln und varicella, lebend abgeschwächt product containing measles virus (live, attenuated), registered in Belgium by GlaxoSmithKline Biologicals. The same ATC class is registered in 10 of our 19 countries.

ATC J07BD54

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedPriorix-TetraATCJ07BD54REGISTER NO.BE-AMP-SAM303843-00PACKS LISTED0CHECKEDSeptember 26, 2026

Where it is registered

Masern, kombinationen mit mumps, röteln und varicella, lebend abgeschwächt is registered in 10 of 19 countries.

Countries holding a registration under ATC J07BD54 (masern, kombinationen mit mumps, röteln und varicella, lebend abgeschwächt), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose

Masern, kombinationen mit mumps, röteln und varicella, lebend abgeschwächt · ATC J07BD54

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Measles virus (live, attenuated)
Manufacturer
GlaxoSmithKline Biologicals
Country
Belgium (BE)
ATC code
J07BD54
ATC class
Masern, Kombinationen mit Mumps, Röteln und Varicella, lebend abgeschwächt
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Masern, kombinationen mit mumps, röteln und varicella, lebend abgeschwächt in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All masern, kombinationen mit mumps, röteln und varicella, lebend abgeschwächt products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7cd65448-4f82-47c5-b5d4-222985f9a4e3
GET /v1/drugs/7cd65448-4f82-47c5-b5d4-222985f9a4e3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder and solvent for solution for injection",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Priorix-Tetra",
  "name_fr": "Priorix-Tetra",
  "name_nl": "Priorix-Tetra",
  "amp_code": "SAM303843-00",
  "strengths": [
    "56.0000",
    "14.0000",
    "14.0000"
  ],
  "pack_count": 3,
  "substances": [
    "Measles virus (live, attenuated)",
    "Mumps virus (live, attenuated)",
    "Varicella-zoster virus (live, attenuated)",
    "Rubella virus (live, attenuated)",
    "Lactose",
    "Mannitol",
    "Sorbitol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Measles, Combinations with Mumps, Rubella and Varicella, Live Attenuated",
  "authorisation_numbers": [
    "BE303843"
  ]
}

See everything about masern, kombinationen mit mumps, röteln und varicella, lebend abgeschwächt.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.